NICE recommends mepolizumab for severe and troubling eosinophilic disease Related items from OnMedica The challenges of asthma Childhood asthma overdiagnosed, warn respiratory doctors Asthma costs UK health service at least £1bn every year Vitamin D supplements reduce severe asthma attacks Hospital discharge of children following asthma attack needs improvement |
No comments:
Post a Comment